Atherosclerosis: should we stop TWEAKing it?
King
Victoria L
VL
D000818:Animals; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics; D050197:Atherosclerosis / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D000074049:Cytokine TWEAK; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D011994:Recombinant Proteins / Q000494:pharmacology; D015398:Signal Transduction; D000074050:TWEAK Receptor; D000079424:Tumor Necrosis Factor Inhibitors; D048069:Tumor Necrosis Factors / Q000494:pharmacology / Q000502:physiology*
D001057:Apolipoproteins E; D000074049:Cytokine TWEAK; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; C109743:TNFSF12 protein, human; D000074050:TWEAK Receptor; C491645:Tnfsf12 protein, mouse; D000079424:Tumor Necrosis Factor Inhibitors; D048069:Tumor Necrosis Factors